Susquehanna International Group, LLP Adamas Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	N/A	-61,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	N/A	800 Added 1.32%	61,400 $301,000
Q2 2021 Aug 11, 2021	SELL	N/A	-40,000 Reduced 39.76%	60,600 $320,000
Q1 2021 May 17, 2021	BUY	N/A	82,200 Added 446.74%	100,600 $483,000
Q3 2020 Nov 16, 2020	BUY	N/A	4,700 Added 34.31%	18,400 $76,000
Q2 2020 Aug 14, 2020	SELL	N/A	-16,300 Reduced 54.33%	13,700 $35,000
Q4 2019 Feb 14, 2020	SELL	N/A	-75,500 Reduced 71.56%	30,000 $114,000
Q3 2019 Nov 14, 2019	BUY	N/A	75,100 Added 247.04%	105,500 $540,000
Q2 2019 Aug 14, 2019	SELL	N/A	-900 Reduced 2.88%	30,400 $188,000
Q1 2019 May 15, 2019	SELL	N/A	-30,000 Reduced 48.94%	31,300 $223,000
Q4 2018 Feb 14, 2019	SELL	N/A	-24,100 Reduced 28.22%	61,300 $524,000
Q3 2018 Nov 14, 2018	SELL	N/A	-28,700 Reduced 25.15%	85,400 $1.71 Million
Q2 2018 Aug 14, 2018	SELL	N/A	-120,500 Reduced 51.36%	114,100 $2.95 Million
Q1 2018 May 15, 2018	BUY	N/A	87,000 Added 58.94%	234,600 $5.61 Million
Q4 2017 Feb 14, 2018	BUY	N/A	147,600	147,600 $5 Million

About Adamas Pharmaceuticals, Inc.

Ticker ADMS
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,408,100
Market Cap $376M

More about ADMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.